CAAS Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,465	Closed	-$2.05M	–	421
2020 Q2	$2.05M	Buy	+16,465	New	+$2.05M	0.07%	91